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Abstract: Chemokine receptor transcripts were de-
fined among CD4 T cells in lymph nodes of mice
with type-1 and type-2 inflammation, respectively,
elicited by mycobacterial and schistosomal Ag.
CXCR3 and CCR6 transcripts were biased to type-1,
and CCR4 transcripts increased in type-1 and type-2
populations. CCR3 and CCR5 signals were too weak
to establish differences. CCR8 transcripts were not
increased among unstimulated populations. Com-
pared to naı̈ve, type-1 and type-2 populations had
reduced CCR7 and enhanced CXCR5 transcripts,
consistent with a shift to memory cells. Subset deple-
tion revealed that transcript expression was induced
among CD44 memory T cells. Surprisingly, CCR3
transcripts were enriched among CD44lo fractions.
Ag stimulation augmented CXCR3, CCR4, and CCR8
but down-regulated CCR6 and CXCR5. CCR4
showed association with IFN-- and IL-4-producing
cells, but other receptor transcripts were expressed
among IFN-/IL-4 negative memory T cells. These
studies provide several novel findings regarding Th
cell chemokine receptor expression in vivo. J. Leu-
koc. Biol. 72: 363–372; 2002.
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INTRODUCTION
Type-1 and type-2 helper T cell (Th1 and Th2, respectively)
subpopulations display distinct patterns of chemokine receptor
expression [1–6]. Chemokine receptor expression by T cells is
considered to be flexible, changing with maturational and
activation state [2, 7]. Generally, artificially generated Th cell
clones or in vitro polarized, polyclonal Th cells have been used
to define chemokine receptor expression patterns for Th1 and
Th2 cells, but it is unclear if these patterns translate to the
more complex in vivo environment. For example, the model
initially developed by Sallusto et al. [8] based on the study of
human Th clones assigned CXCR3 and CCR5 expression to
Th1 memory cells and CCR3 and CCR4 to Th2 memory cells,
but a recent study of human peripheral blood revealed that
cells with Th1 and Th2 characteristics expressed CCR4 [9, 10].
Thus, it is becoming increasingly apparent that chemokine
receptor expression among T cells in the in vivo environment is
complex and subject to endogenous, tissue-derived, microen-
vironmental and exogenous, pathogen-derived regulatory sig-
nals. Therefore, efforts to exploit chemokine receptor dynamics
for clinical benefit must involve detailed in vivo analyses.
To this end, we measured transcript levels for multiple
chemokine receptors among CD4 T cell populations isolated
from draining lymph nodes in models of Th1 and Th2 cell-
mediated, pulmonary, granulomatous inflammation, elicited,
respectively, by antigens derived from Mycobacteria bovis and
ova of the helminthic parasite, Schistosoma mansoni [11–13].
These models provide a unique means to directly compare
chemokine receptor expression under highly polarized in vivo
conditions. A broad spectrum of reliable antibodies (Ab) with
specificity for mouse chemokine receptors is not available, but
the recent advent of real-time reverse transcriptase-polymerase
chain reaction (RT-PCR) technology has permitted highly sen-
sitive and reproducible, quantitative detection of chemokine
receptor transcripts. Using this approach, we herein demon-
strate distinct shifts of receptor transcript expression among
CD4 Th cell populations generated in vivo during type-1
mycobacterial and type-2 schistosomal granulomatous re-
sponses. Our in vivo study provides a number of novel obser-
vations, some of which challenge certain aspects of paradigms
derived from in vitro T cell clone analyses. Overall, the find-
ings support the concept of flexible chemokine receptor ex-
pression by T cells and provide in vivo evidence, suggesting
that sensitization with strongly polarizing antigens (Ag) leads to
induction of common and restricted chemokine receptor ex-
pression among broad, polyclonal T memory cell populations.
MATERIALS AND METHODS
Animals
Female, CBA/J mice were obtained from Jackson Laboratories (Bar Harbor,
ME). All mice were maintained under specific pathogen-free conditions and
were provided food and water ad libitum.
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In vivo generation Th1 and Th2 immune
responses
Type-1 and type-2 secondary Ag-bead pulmonary, granulomatous responses
were generated in CBA mice as previously described [12]. Briefly, mice were
sensitized by subcutaneous injection of 20 g M. bovis purified protein
derivative (PPD; Department of Agriculture, Veterinary Division, Ames, IA)
incorporated into 0.25 ml complete Freund’s adjuvant (#F-5881, Sigma Chem-
ical Co., St. Louis, MO) or 3000 S. mansoni eggs suspended in 0.5 ml
phosphate-buffered saline (PBS). Fourteen to 16 days later, PPD and schisto-
some egg-sensitized mice were, respectively, challenged by tail vein with 6000
Sepharose 4B beads (in 0.5 ml PBS) covalently coupled to PPD or to S.
mansoni-soluble schistosome egg antigens (SEA) obtained from the World
Health Organization (Geneva, Switzerland). Draining mediastinal lymph nodes
were collected from five mice on day 3 and were pooled for CD4 T cell
purification described below. Replicates consisted of separate studies using
five mice per group in each study. To confirm polarization, culture supernates
were analyzed by enzyme-linked immunosorbent assay (ELISA) for cytokine
profiles as described [14].
To examine the effect of Ag stimulation on Th cell chemokine receptor
expression, draining mediastinal lymph nodes from type-1 (PPD)- or type-2
(SEA)-sensitized and bead-challenged animals were dispersed and cultured for
48 h in media supplemented, respectively, with 5 g/ml PPD or SEA as
previously described [14]. Next, CD3CD4 T cells were isolated as de-
scribed below and subjected to mRNA analysis.
Real-time RT-PCR analysis of mRNA
Poly(A) pure mRNA was isolated from cells using Poly(A)Pure mRNA isolation
kits (Ambion, Austin, Texas). Each mRNA sample of approximately 1 g was
reverse-transcribed in a 20-l reaction in a PCR reaction tube using reverse
transcription system kits (Promega, Madison, WI). Four separate reactions
were conducted to minimize variability between tubes. The products from each
reaction tube were pooled to make one cDNA sample. ABI PRISM 7700
Sequence Detection System (Perkin-Elmer, Foster City, CA) was used for
real-time PCR analysis. For the current study, a comparative method (see User
Bulletin #2, Perkin-Elmer) was adopted with glyceraldehyde 3-phosphate
dehydrogenase as endogenous reference, and TaqMan (Perkin-Elmer) prede-
veloped reaction kits for mouse chemokine receptors CXCR2, CXCR3,
CXCR5, CCR1, CCR2, CCR3, CCR4, CCR5, CCR6, CCR7, and CCR8 were
used for amplification. In all cases, the thermal cycling condition was pro-
grammed according to the manufacturer’s instructions. To verify purity of
mRNA, real-time PCR was perfomed on samples before and after reverse
transcription, and it was routinely demonstrated that 37 or more PCR cycles
were required to detect any activity in nontranscribed samples, indicating very
low DNA contamination. For each chemokine receptor, the mRNA was con-
sidered detectable only when the signal was tenfold more abundant than the
contamination level. In addition, an undetectable receptor gene among our
panel of multiple receptors indicated lack of DNA contamination. Among the
CD4 T cell mRNA, CXCR2 and CCR1 transcripts were consistently nega-
tive.
Data are expressed as arbitrary units (AU), which are calculated from the
fluorescence amplication factor as measured by the real-time PCR, fluorescent
detection unit. The original gene copy number (Co) is related to fluorescence
of the generated signal as follows: Co  F  E1  I  2n, where F is an
arbitrary conversion constant, E1 is amplification efficiency constant (approx-
imately 1 for manufacturer’s real-time primers sets), I is the fluorescent-
intensity reading, and n is the amplification cycle number. Hence, F  E1 
I  2n constitutes an arbitrary measure of original copy number that is
directly related to the fluorescent product and inversely related to cycle
number. As E is roughly equivalent for the various primer sets, the expression
levels among genes are comparable at orders of magnitude, but because of
possible minor variations in reaction conditions between assays, a single
Y-scale cannot be applied to all data.
Flow cytometric analysis of cytoplasmic
cytokines
Ten million Th cells were suspended in 3 ml culture media with anti-CD28 at
2 g/ml and were restimulated on an anti-CD3-coated 35-mm culture dish.
Alternatively, in some studies, lymph node cells (5106/ml) were stimulated
with specific Ag. One hour after the initial stimulation, 2 L GolgiStop
(Pharmingen, San Diego, CA) was added to the culture media. The cells were
cultured for another 4 h in a 37°C 5% CO2 humidified incubator and then
collected in cold PBS. Fixation was done with 1 ml CytoFix/CytoPerm (Pharm-
ingen). After blocking with 10% bovine serum albumin, the cells were stained
with the following phycoerythrin (PE)-labeled antibodies: rat immunoglobulin
G (IgG)1-PE (isotype control), rat anti-mouse-interferon- (IFN-)-PE or cy-
tochrome-labeled antibodies, rat anti-mouse-interleukin (IL)-4-PE, rat IgG2a-
Cy-chrome, and rat anti-mouse-CD4-Cy-chrome (all from Pharmingen). A
FACScan flow cytometer with CellQuest software (Becton-Dickinson, San Jose,
CA) was used for data acquisition and analysis. Ten thousand events per
sample were analyzed. In vitro-generated Th1 cells were routinely IL-4 neg-
ative and greater than 95% IFN- producing, whereas in vitro-generated Th2
cells were IFN- negative, and 40–50% of the cells were IL-4-producing. For
chemokine receptor analysis, Th2 cells were further enriched as described
below.
T cell subpopulation enrichment and depletion
Single cell suspensions were prepared from freshly harvested lymph nodes.
The red blood cells and dead cells were removed from the preparations by
using density centrifugation on Lympholyte-M (Cedarlane, Hornby, Ontario).
Mouse T cell CD4 subset column kits (R&D Systems, Minneapolis, MN) were
used to enrich for CD3CD4 cells. The purity of the recovered cells was
confirmed by flow cytometric analysis and was routinely greater than 95%. For
CD3 CD4 CD25 and CD3 CD4 CD44 subpopulation depletion,
biotinylated anti-CD25 or anti-CD44 antibodies (Pharmingen) were added into
the CD3 CD4 cell enrichment cocktail (StemCell Technologies, Vancou-
ver, BC, Canada). Cells were then incubated with the enrichment cocktails,
and the unwanted cells were magnetically labeled and removed according to
the manufacturer’s protocol. CD25 depletion routinely removed 30  14% and
CD44 depletion, 50  15% of draining lymph node CD4 T cells.
A similar procedure was used for CD4IFN- and CD4IL-4 cells
enrichment. Cytokines from antigen-stimulated T cells were released and then
captured on the cell surface by using cytokine secretion assay cell enrichment
and detection kits (#130-054-101, Miltenyi Biotech GmbH, Bergisch Glad-
bach, Germany). Biotinylated anti-IFN- or anti-IL-4 antibodies (Pharmingen)
were added into the CD3 CD4 cell enrichment cocktail (StemCell Tech-
nologies), and the target cells were magnetically removed. Treated and control
cell fractions were analyzed for IFN- and IL-4 transcripts to confirm deple-
tion. In addition, flow cytometric detection of cytoplasmic cytokine expression
was further used to confirm depletion.
Cytokine measurement
Mouse IL-4 and IFN- were measured by ELISA using commercially available
reagents (Pharmingen and R&D Systems); sensitivities ranged from 10 to 50
pg/ml. Commercially available, recombinant murine cytokines served as stan-
dards in all assays (Genzyme, Cambridge, MA; Preprotech Inc., Rocky Hill,
NJ; and R&D Systems).
Statistics
Analysis of variance with Tukey or Bonferoni error protection was used for
intergroup comparisons. Values of P  0.05 were considered to indicate lack
of significance.
RESULTS
Draining lymph node CD4 Th cells display
novel profiles of chemokine receptor transcripts
during in vivo-polarized type-1 (mycobacterial)
and type-2 (schistosomal) immune responses
To assess Th chemokine receptors under in vivo polarizing
conditions, we examined CD4 T cells using well-described in
vivo models of type-1 and type-2 polarized immune responses
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induced by protein Ag of M. bovis bacteria or S. mansoni eggs,
respectively [12]. In these models, mice are sensitized with a
PPD of M. bovis or soluble Ag from S. mansoni eggs (SEA)
followed by an intravenous challenge of agarose beads co-
valently coupled to the respective sensitizing Ag. The Ag-
coated beads embolize to the lung where they induce type-1
and type-2 cytokine-dependent, inflammatory responses with
correspondingly highly polarized Th1 and Th2 cytokine pro-
files in draining lymph nodes [13, 14]. In the present study,
draining lymph nodes from the mediastinum were collected
and subjected to multiple analyses 3 days after Ag-bead chal-
lenge. Figure 1A compares levels of IFN- and IL-4 in the
cultured lymph node cells and clearly demonstrates the ex-
pected polarized Th1 and Th2 cytokine production in PPD
(type-1) and SEA (type-2) models. Figure 1B shows a typical
flow cytometric analysis of cytoplasmic cytokine expression
among CD4 T cells in the Ag-stimulated lymph nodes.
Approximately 3–4% of CD4 T cells expressed IFN- in the
type-1 cultures with no significant IL-4-positive cells detected.
In type-2 cultures, about 2% of CD4 T cells expressed IL-4
with no significant IFN--positive cells detected. These find-
ings further confirmed distinct cytokine polarization in these
models.
Next, CD4 T cells purified from freshly harvested lymph
nodes from naı̈ve mice or those draining the bead-challenged
lungs of sensitized mice and were subjected to chemokine
receptor transcript analysis by real-time RT-PCR. As shown in
Figure 1C, CD4 T cell populations from type-1 (PPD) and
type-2 (SEA) lymph nodes displayed detectable shifts in che-
mokine receptor transcript profiles as compared with naı̈ve
CD4 T cells. As demonstrated for in vitro-generated Th1
cells, CXCR3 transcripts were strongly enhanced in the type-1
(PPD) response. The CCR3 transcript signals were too weak to
define clear differences. Similarly, draining lymph node CD4
T cells showed weak CCR5 transcript expression without evi-
dence of polarization to the Th1 response as demonstrated for
Fig. 1. Chemokine receptor transcript expression by
draining lymph node CD4 T cells from mice with
type-1 (PPD) and type-2 (SEA) T cell-mediated gran-
uloma formation. (A) IFN- and IL-4 production by
Ag-stimulated, draining type-1 (PPD) and type-2
(SEA) lymph node cultures demonstrating polarized
cytokine expression. (B) Flow cytometric analysis of
cytoplasmic IFN- and IL-4 expression by type-1
(PPD) and type-2 (SEA) Ag-stimulated, draining
lymph node CD4 T cells. Numbers in upper-right
quadrants indicate percentage of specific Ag reactive,
CD4 T cells expressing cytokine. Scattergrams are
representative of three experiments. (C) Chemokine
receptor transcript expression by freshly isolated
lymph node CD4 T cells from naı̈ve mice (NML)
and mice with type-1 (PPD) or type-2 (SEA) pulmo-
nary granulomatous inflammation. Bars are mean
AU  SD derived from three separate experiments. *,
P  0.05.
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in vitro-generated cells [15, 16]. It should also be noted that
levels of CXCR2, CCR1, and CCR2 transcripts among CD4
lymph node preparations were likewise consistently weak (data
not shown).
A distinctly novel finding of this study was that the CCR6
message was strongly expressed by and biased to type-1 (PPD)
CD4 T cells (Fig. 1C). CCR4 was induced among type-1
(PPD) and type-2 (SEA) populations with a trend to greater
expression among the former. Specifically, among type-1
CD4 T cells, CCR4 transcripts were sixfold above, and
type-2 CD4 T cells were threefold above the naı̈ve CD4 T
cells. Levels of CCR8 transcripts were comparable with naı̈ve
cells among type-1 preparations and were significantly reduced
among type-2 CD4 T cells. These findings regarding CCR4
and CCR8 transcript expression were unexpected, as artifi-
cially generated Th2 cells express these receptors [17, 18].
The above findings indicated induction of restricted and
shared chemokine receptor transcripts among type-1 and
type-2 CD4 T cell populations. Type-1 populations showed
induction of CXCR3, CCR4, and CCR6, whereas type-2 prep-
arations showed enhancement of only CCR4 transcripts. As
lymph node CD4 T cells likely represent a mix of naı̈ve and
memory T cells as well as quiescent and activated cells, further
subpopulation analysis was needed for better interpretation.
CD44 memory T cells primarily express
induced chemokine receptor transcripts among
CD4 T cells during type-1 (mycobacterial) and
type-2 (schistosomal) immune responses
Type-1 (PPD) and type-2 (SEA) draining lymph node CD4 T
cells were next analyzed for CCR7 and CXCR5 transcripts,
chemokine receptors reportedly respectively, associated with
naı̈ve and Ag-primed memory T cells [19, 20]. As shown in
Figure 2, freshly isolated CD4 T cells from PPD- and
SEA-sensitized and -challenged mice displayed a significant
decrease in CCR7 expression and increase in CXCR5 expres-
sion when compared to those from lymph nodes of age-matched
NML mice. This result suggested a decrease in naı̈ve T cells
and expansion of Ag-primed, CD4 memory T cells. More-
over, similar shifts from naı̈ve to CXCR5 memory popula-
tions occurred in type-1 and type-2 responses, an observation
not previously reported.
We next analyzed chemokine receptor mRNA in type-1
(PPD) and type-2 (SEA) draining node CD4 T cells depleted
of CD44 (memory) cells or CD25 (recently activated) cells.
The latter marker was used because activation alters chemo-
kine receptor expression [8]. As shown in Figure 3A, CCR7
was enriched by three- to fourfold among type-1 and type-2
CD4 T cells after depletion of CD44 cells. Conversely,
CXCR5, which is expressed by memory T cells, was largely
eliminated by CD44 cell depletion (Fig. 3B). This argued
that the method was indeed depleting the memory CD44hi,
CCR7- T cell population. Interestingly, depletion of CD25
cells significantly augmented CXCR5 transcript levels, sug-
gesting the presence of a CD25 population with low or absent
CXCR5 transcript expression, which was partially diluting the
mRNA pool. Figure 3C demonstrates that the enhanced ex-
pression of CXCR3 in the type-1 response was also associated
with CD25, CD44 memory T cells but not CD25 cells. As
before, CCR3 transcript expression remained weak, but deple-
tion of CD44 cells consistently augmented levels among
type-2 preparations, indicating that CCR3 was expressed by a
CD44lo population, and a similar trend was observed in type-1
preparations (Fig. 3D). The possibility of a novel CCR3,
naı̈ve CD4 population will require further investigation.
CCR4 transcripts were also associated with memory T cells in
type-1 and type-2 responses (Fig. 3E). CCR5 mRNA again
remained low, and significant depletion-related effects were
not demonstrable (Fig. 3F). As noted above, CCR6 transcripts
were strongly biased to the type-1 response and were clearly
associated with memory T cells. It is interesting that CCR8
transcripts showed reductions following CD25 cell depletion
as well as 80–90% reductions with depletion of CD44 cells
in both types of responses. This finding suggested the presence
of a CD25, CCR8 T memory cell population. Taken to-
gether, these results indicated that CD44 memory T cells
were responsible for much of the induced chemokine receptor
transcripts following adaptive sensitization to PPD and SEA,
whereas the naı̈ve CD44 population expressed mainly CCR7.
To summarize, in the type-1 (PPD) response, CD4,
CD44 memory cells showed enhanced CXCR5, CXCR3,
CCR4, and CCR6 mRNA, and in the type-2 (SEA) response,
CD4 T cells had a more limited repertoire, showing increases
only of CXCR5 and CCR4 when compared with nonimmune
lymph node CD4 T cells. In addition, subpopulations of
CD25 (presumably activated), CD4 T cells were detect-
able, which were CCR8.
Fig. 2. CCR7 and CXCR5 transcript expression by draining lymph node
CD4 T cells from mice with type-1 (PPD) and type-2 (SEA) T cell-mediated
granuloma formation. Transcripts expression was measured in freshly isolated
lymph node CD4 T cells from NML and mice with type-1 (PPD) or type-2
(SEA) pulmonary granulomatous inflammation. Bars are mean AU  SD
derived from three separate experiments. *, P  0.05.
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Ex vivo antigen stimulation differentially regulates
chemokine receptor transcript expression by
CD4 T cells
As T cell receptor (TCR)-mediated activation regulates che-
mokine receptor expression for up to 72 h of in vitro culture [8],
we examined the effect of ex vivo culture and specific Ag-
mediated activation on chemokine transcripts. To this end,
chemokine receptor transcripts were analyzed in CD4 T cells
from draining lymph nodes of mice with type-1 (PPD) and
type-2 (SEA) granulomatous responses that were freshly iso-
lated or cultured for 48 h in the presence or absence of specific
Ag. The findings revealed that culture and antigen stimulation
had differing effects on chemokine receptor transcripts. As
illustrated in Figure 4A, Ag stimulation further reduced levels
of CCR7 transcripts in type-1 and type-2 cultures. Levels of
CXCR5 mRNA did not appear to be stable to culture since
among type-1 CD4 T cells, culture with or without Ag also
caused about a 90% reduction of CXCR5 (Fig. 4B). A similar
trend occurred in type-2 cells, but this did not reach signifi-
cance in unstimulated cultures; however, Ag stimulation did
cause an 80% reduction in CXCR5 mRNA expression. Acti-
vation-mediated down-regulation of CXCR5 expression would
be commensurate with the observed enrichment of CXCR5
transcript levels after depletion of CD25 cells (Fig. 3B).
Ag stimulation also affected other chemokine transcripts. As
shown in Figure 4C, CXCR3 receptor transcripts levels were
stable to culture without Ag but increased twofold among
type-1 (PPD) CD4 T cells when cultured with Ag. Type-2
cells displayed lower expression than naı̈ve cells after Ag
stimulation, possibly indicating negative regulation. CCR3
transcripts among type-2 (SEA) CD4 T cells were low with no
consistent changes demonstrable (Fig. 4D). CCR4 transcripts
were stable to culture, and Ag stimulation enhanced expression
among type-1 and type-2 CD4 T cells by three- and twofold,
respectively. (Fig. 4E). As above, CCR5 transcript levels re-
mained low with no clear changes (Fig. 4F). The biased ex-
pression of CCR6 transcripts by type-1 (PPD) CD4 T cells
was stable to culture without Ag but decreased by 90% fol-
lowing Ag stimulation (Fig. 4G). Interestingly, the low CCR6
signal in the type-2 response (only 10–15% of that in the
type-1 response) also showed a further decline with Ag stim-
ulation. Finally, Ag stimulation strongly enhanced CCR8 tran-
scripts above naı̈ve levels and by three- and fourfold above
freshly isolated type-1 and type-2 CD4 T cells, respectively.
Fig. 3. Chemokine receptor transcript association with CD44 memory and
CD25 activated CD4 T cells from draining lymph node of mice with type-1
(PPD) and type-2 (SEA) T cell-mediated granuloma formation. Freshly isolated
lymph node CD4 T cells were subjected to chemokine transcript analysis
following column depletion of CD25 or CD44 cells as described in
Materials and Methods. Bars are mean AU  SD derived from two separate
experiments. *, P  0.05 as compared with unfractionated control cells (CON).
Fig. 4. Effect of specific antigen stimulation on chemokine receptor transcript
expression by draining lymph node CD4 T cells from mice with type-1 (PPD)
and type-2 (SEA) T cell-mediated granuloma formation. Transcript levels were
analyzed in isolated CD4 T cells by real-time RT-PCR after culture for 48 h
in the absence or presence of 5 g/ml PPD or SEA. Bars are mean AU  SD
and are derived from two separate experiments. *, P  0.05 as compared with
freshly isolated CD4 T cells. Dashed lines indicate level of expression by
naı̈ve CD4 T cells.
Chiu et al. Chemokine receptors in Th1 and Th2 responses 367
This stimulation-mediated enhancement was consistent with
our observation that CCR8 expression was associated with cells
bearing the CD25 activation marker.
Although these observations may not reflect changes in
Ag-specific CD4 T cell subpopulations, they indicate that
chemokine receptor transcript levels are independently regu-
lated by Ag stimulation. The receptors could be divided into
two main groups: those enhanced by Ag and those down-
regulated by Ag stimulation. Among type-1 cells, CCR6, an
apparent marker of type-1 memory cells, was profoundly down-
regulated following Ag stimulation, and CXCR3, CCR4, and
CCR8 were enhanced. Among the type-2 cells, CCR4 and
CCR8 transcripts were also enhanced by Ag stimulation, and
CCR3 showed no clear changes. Finally, CXCR5 transcripts
were decreased in type-1 and type-2 cultures following culture
and Ag stimulation.
Induced chemokine receptor transcripts are not
limited to Th1 (IFN-) or Th2 (IL-4) cytokine-
producing T cells
As PPD and SEA Ag-specific, cytokine-producing cells repre-
sent only 2–5% of the type-1 and type-2 CD4 T cell popu-
lations, it was surprising that distinct patterns of induced
chemokine receptor expression could be so easily detected on
whole population analysis. To determine the contribution of
IFN-- and IL-4-producing T cells to the observed levels of
chemokine receptor transcripts, we analyzed populations after
depletion of Ag-elicited, cytokine-producing cells. Cytokine-
producing cells were eliminated after 24 h of Ag stimulation
using commercially available depletion kits. Figure 5 shows
the levels of IFN- and IL-4 transcripts in control and depleted
preparations. Control populations again showed distinct polar-
ization by transcript analysis as they did by flow cytometric and
ELISA analyses (Fig. 1). Upon depletion, IFN- transcripts
were reduced by greater than 60% among type-1 and IL-4
transcripts, by greater than 80% among type-2 CD4 cells,
indicating that the method was reasonably effective in reducing
target, cytokine-producing cells. The cytokine transcripts were
also shown to be limited to the CD44 fraction (Fig. 5).
Figure 6 shows the normalized chemokine receptor analysis of
these preparations expressed as percent change from the con-
trol. In addition, parallel analyses of memory cell (CD44)-
depleted, Ag-stimulated cultures are shown. Of the analyzed
receptors, CCR4 showed the greatest association with the
IFN-- or IL-4-producing cells, and to a lesser extent, CXCR3
showed some association with IFN- cells. Changes in CCR4
transcripts were greater in the treated type-2 populations, but
this may have been because of the better depletion efficiency in
these preparations. In memory cell-depleted cultures, there
was again enrichment of naı̈ve T cell-associated CCR7 and
virtually complete elimination of CCR4, CCR8, and CXCR3
transcripts. As we observed for fresh, unstimulated CD4 T
cell preparations, CCR3 segregated to the nonmemory
(CD44lo) cell fraction. As transcripts for CCR6 were down-
regulated on CD44 cells following stimulation, no segrega-
tion was detected (data not shown).
These results indicated that the bulk of the Ag-induced,
chemokine receptor transcript expression was among popula-
tions not secreting IFN- and IL-4, but CCR4 did show a
significant association with cytokine-producing Th1 and Th2
cells. Moreover, this induction was restricted to the memory T
cell fraction.
DISCUSSION
Chemokine receptors are likely important determinants of T
cell functional behavior in adaptive immune responses, and in
vitro analyses have provided important insights into the dy-
namic nature of T cell chemokine receptor expression [3, 4, 7,
21–23]. These findings have led to a paradigm that purports a
flexible program of chemokine receptor expression that
changes as T cells mature from early thymic stages to effector/
helper cells. In the periphery, as naı̈ve CD4 T cells mature
to Th1 and Th2 cells, they are considered to acquire distinct
patterns of chemokine receptor expression. This paradigm is
being tested in human disease conditions and animal models.
In the present study, we examined CD4 T cell chemokine
receptor transcript expression using in vivo models of type-1
and type-2 T cell-mediated inflammation elicited by Ag of M.
bovis bacteria (PPD) and S. mansoni eggs (SEA), respectively.
Fig. 5. Cytokine transcript expression following targeted depletion of IFN--,
IL-4-, and CD44-positive T cells from mice with type-1 (PPD) and type-2
(SEA) T cell-mediated granuloma formation. Type-1 or type-2 draining lymph
node cells were, respectively, stimulated for 24 h with PPD or SEA Ag, and
then specific depletions were performed as described in Materials and Meth-
ods. (A) IFN- mRNA in control and depleted fractions. (B) IL-4 mRNA in
control and depleted fractions. Bars are mean AU  SD and derived from five
mice. *, P  0.05 as compared with control preparations cultured and treated
in parallel.
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These models are well characterized and involve highly polar-
ized Th1 and Th2 cytokine participation [11–13]. This study
represents one of the most extensive analyses of T cell chemo-
kine receptor transcript expression performed using in vivo
models of polarized Th cell responses. We used real-time
RT-PCR for transcript analysis, which provided a powerful tool
to detect changes in cell subpopulations that could not be
studied directly as a result of limited cell numbers and lack of
reliable, specific, anti-mouse, chemokine receptor Ab. The
method is of course limited in that transcript levels may not
reflect levels of protein expression and biologic activity; nev-
ertheless, transcript analysis has, to date, been the dominant
parameter used for chemokine receptor studies in humans and
animals. It is likely that transcript levels reflect at least some
degree of protein expression, as in our initial verification,
studies of artificially polarized mouse Th cell chemokine re-
ceptor transcripts correlated well with chemotactic responses
and matched expression patterns demonstrated by others (data
not shown).
Remarkably, our analysis detected patterns of biased che-
mokine receptor transcript expression among polyclonal CD4
T cell populations isolated from lymph node-draining lungs
with ongoing type-1 (PPD) and type-2 (SEA) granulomatous
inflammation. With respect to CXCR3, the biased expression
pattern matched that shown for artificially generated Th1 and
Th2 cells [1]. Like artificially generated Th1 cells, type-1 PPD,
Ag-elicited CD4 T cells were associated with dominant ex-
pression of CXCR3, whereas type-2 T cells showed no induc-
tion over naı̈ve populations. Thus, we provide further support
for CXCR3 as a marker of type-1 polarization at least within
the lymph node environment. With regard to the other receptor
transcripts, we observed novel expression patterns that differed
from those that would be predicted from artificially polarized
cells. These findings are discussed below.
Unlike reports for in vitro-generated Th2 clones [17, 24],
CCR3 and CCR4 did not polarize to type-2 CD4 populations.
Selective CCR3 expression by Th2 cells has been subject to
controversy and has not been consistently detected in type-2-
related, human disease conditions [5, 25]. We noted weak
baseline signal in our populations, but to our surprise subse-
quent studies consistently showed enhanced expression in
enriched CD44lo fractions. It is unknown if this reflects ex-
pression by naı̈ve cells or the presence of a novel, specialized
CD4, CD44lo, CCR3 population. Further studies will be
required to determine the significance of this finding. CCR4
transcripts were induced in both responses and tended to be
greater in the type-1 than in type-2 populations. Enhanced
CCR4 has been shown among T cells in Th2-related human
disease, but this was not directly compared with a Th1-related
disease [5, 25]. Our results appear to agree with a recent study
of human blood T cells demonstrating CCR4 expression by
memory Th1 and Th2 cells and implicating CCR4 as a major
trafficking receptor for Th cells in general [10].
Also contrasting with in vitro Th cell patterns was CCR5,
which is associated with Th1 clones [2, 15], but provided only
a weak signal and no distinct polarization among in vivo type-1
lymph node CD4 T cell populations. Using flow cytometric
analysis with available antimurine CCR5 Ab, we have ob-
served weak expression and lack of polarization among freshly
isolated blood and lymph node CD4 T cells in our models;
however, greater expression was detected among T cells iso-
lated from PPD- but not SEA-bead granulomas (unpublished
results). In accord with our findings, Iwasaki et al. [26] dem-
onstrated that mouse T cells lack CCR5 transcript expression
until exposed to IL-12. Thus, Th cells may acquire CCR5
expression upon contact with sites of local IL-12 production as
with the type-1 (PPD) granuloma [27].
Our analysis of CCR6 transcript expression provided the
novel observation that it was strongly biased to type-1, PPD-
elicited CD4 T cell preparations. Like the other induced
receptors, it was associated with CD44 memory T cells. The
CCR6 receptor is a unique 	-chemokine receptor that is ex-
pressed mainly in lymphoid tissues [28, 29]. Although memory
CD4 T cells are known to express CCR6 [30, 31], selective
expression by Th1 subsets has not been shown. We also
demonstrated Ag-mediated regulation of this receptor, which is
discussed in more detail below.
Another surprising finding was that type-2 CD4 T cells
displayed reduced transcripts for CCR8, a receptor usually
associated with in vitro Th2 cells [17, 18, 32]. Not only did we
fail to observe CCR8 polarization among type-2 populations,
baseline transcript levels were below that of naı̈ve CD4 T cell
Fig. 6. Net change in chemokine receptor transcript expression following
targeted depletion (Dep) of IFN--, IL-4-, and CD44-positive T cells from mice
with type-1 (PPD) and type-2 (SEA) T cell-mediated granuloma formation.
Cultures were prepared and treated as in Figure 5 and then analyzed for
chemokine receptor transcripts. (A) Effect of IFN- and IL-4 cell deple-
tion in respective type-1 and type-2 CD4 T cell populations. (B) Effect of
CD44 cell depletion in type-1 and type-2 populations. Bars are mean percent
change from control preparations cultured and treated in parallel. Normalized
data are presented as a result of different signal intensity among receptor types.
A negative 100% change is maximum elimination of signal. Positive changes
indicate enrichment over control.
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preparations. However, CCR8 transcripts were associated with
CD44 memory cells and appeared to be expressed at least to
some extent by CD25 T cells. In fact, among the chemokine
receptors we examined, CCR8 demonstrated the greatest pos-
itive association with CD4 CD25 T cells. These cells
appeared to be Th memory cells, as they were associated with
the CD44 component, unlike the recently described CD4
CD25 “professional suppressor” cells that lack memory phe-
notype [33]. These findings invoke the possibility that CCR8
displays stage-specific or activation-related expression.
Another novel finding was our demonstration that sensitiza-
tion caused comparable inductions of CXCR5 and decreases in
CCR7 expression in type-1 (PPD) and type-2 (SEA) T cells.
This was fully consistent with a shift to T memory cells, and
indeed the CXCR5-expressing population correlated positively
to CD44 and negatively with the CD25 activation marker
upon fractionation analysis. That these populations were so
easily detected by transcript analysis suggests that our sensi-
tization protocol caused a considerable expansion of the mem-
ory cell population.
Our findings regarding the effect of Ag activation on che-
mokine receptor transcript expression by type-1 (PPD) and
type-2 (SEA) CD4 T cell preparations agrees in most re-
spects with transcript analyses of Sallusto et al. [8] using TCR
cross-linked human Th cells. Like that study, we observed
down-regulated CCR6 and enhanced CCR4 and CCR8 tran-
scripts following stimulation, but unlike that study, we ob-
served abrogation of CXCR5. We also observed that removing
T cells from the lymph node environment and culturing them
ex vivo in the absence of a stimulus tended to decrease CXCR5
receptor transcript expression among type-1 and type-2 CD4
T cells. This finding suggested that certain receptors may be
unstable in the ex vivo environment. In addition, CXCR5
showed an inverse correlation with CD25 (IL-2 receptor) ex-
pression and was further reduced with Ag stimulation expres-
sion. Our observation is consistent with activation-mediated
down-regulation of CXCR5, as demonstrated in human tonsil T
cells [34, 35]. The effect could be mediated by IL-2, which
down-regulates CXCR5 expression [8]. CXCR5 is thought to
confer B cell follicle homing capacity and has been associated
with “follicular B helper T cells” [34, 35]. Thus, loss of CXCR5
expression during culture may impair the capacity of Th cells
to home to B cell zones [20, 36], a finding with potential
implications for T cell homing studies.
As for other receptor transcripts, CXCR3, CCR4, and CCR8
displayed two- to fourfold enhancements among the type-1
CD4 T cell populations, presumably providing potential re-
sponsiveness to several different chemokines. Enhanced ex-
pression of chemokine receptors by Ag stimulation is thought
to promote post-activation functions, such as emigration
through interstitial spaces to sites of inflammation or regulation
of secretory events [7]. Unlike the type-1, type-2 CD4 T cell
preparations had a more limited repertoire, with CCR8 being
enhanced by fourfold and CCR4 by only twofold. Indeed,
CCR8 emerged as a relatively dominant signal among type-2
preparations after stimulation. This finding has particular rel-
evance to our recent report showing deficits of the Th2 but not
the Th1 response in CCR8 knockout mice [37]. Those findings
were initially thought to reflect biased expression of CCR8 by
Th2 cells, but as discussed below, our current study would
indicate that memory CD4 T cells other than those producing
IL-4 can express CCR8. Consequently, effects of CCR8 knock-
out on other effector or regulatory populations must be consid-
ered.
Finally, the profound abrogation of CCR6 mRNA among
type-1 T cells following stimulation would argue that it serves
a preactivation function, such as attracting Th1 cells to lym-
phoid tissues or sites of likely Ag encounter. CCR6 is strongly
expressed by dendritic cells and B cells [29–31, 38–40], and
the only known ligand for CCR6 is CCL20 (liver and activa-
tion-regulated chemokine/Exodus/macrophage inflammatory
protein-3
), which appears to be expressed primarily by epi-
thelial cells, including those of liver, intestine, pancreas, and
skin [29, 41–43]. Thus, CCR6 has been implicated in immune
responses involving epithelial surfaces and the epithelial lo-
calization of dendritic cells [39, 44]. Recently, Cook et al. [45]
demonstrated impairment of mucosal immunity in CCR6
knockout mice, and in an independent study, Varona et al. [46]
noted abrogated T cell-mediated, delayed-type responses to
cutaneous challenge with allogeneic cells following adoptive
sensitization with T cells from CCR6 knockout mice. Relevant
to these studies, Fitzhugh et al. [47] demonstrated that CCR6
promotes adherence to dermal endothelium, and Homey et al.
[48] showed that CCR6 is highly expressed by skin-homing
memory T cells in psoriatic lesions. These reports, taken
together with our present findings, would support the notion
that CCR6 promotes localization of memory Th1 cells to epi-
thelial-rich organs or epithelial-associated lymphoid tissues.
Our analysis of Ag-stimulated type-1 and type-2 CD4 T
cell populations, respectively, depleted of IFN-- and IL-4-
producing cells was particularly revealing. Of the receptor
transcripts enhanced by Ag stimulation, CCR4 showed the
greatest association with these cytokine-producing popula-
tions. As these populations represent only 2–5% of the overall
CD4 T cell populations, our ability to detect this association
by transcript analysis would indicate strong expression in this
fraction. The other receptor transcripts for CXCR3 and CCR8
remained in large part with the remaining memory T cell
fraction, indicating expression by populations other than
IFN-- and IL-4-positive cells. Thus, CCR4 appears to be an
important effector cell-expressed chemokine receptor, and it
should be noted that an important ligand of CCR4, CCL17—
i.e., thymus activation-related chemokine—is induced locally
in lungs with type-1 (PPD) and type-2 (SEA) granuloma for-
mation and has been shown to support CCR4 T cell recruit-
ment to Propionibacterium acnes granulomas [49, 50]. The
relatively minor association of CXCR3 with an IFN--produc-
ing fraction was surprising, but several possible explanations
can be offered. First, we could only deplete Ag-specific cells
with the greatest IFN--producing capacity, and we suspect
there may be other Th1 clones remaining with weaker IFN--
producing capacity that may express CXCR3; this would ex-
plain our inabilty to deplete no more than 60% of the IFN-
transcripts. Second, and as recently demonstrated by Kim et al.
[51], Tnp (IFN- IL-4) memory cells can express CXCR3.
Hence, a significant component of noncytokine-producing
CD4 T cells may express CXCR3. Finally, it is unclear to
what extent the Th1 cytokine environment may induce CXCR3
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expression on bystander T cell clones that are unreactive to
PPD antigen stimulation.
In conclusion, our study supports the notion of flexible
programs of T cell chemokine receptor expression and shows
that distinct profiles of chemokine receptor transcripts can be
detected among draining lymph node CD4 T cell populations
derived from in vivo models of polarized type-1 (PPD) and
type-2 (SEA) immune responses. The findings emphasize the
complexity of T cell chemokine receptor expression dynamics
in the in vivo environment and point to new avenues of inves-
tigation. They show that strongly polarizing Ag can influence
net chemokine receptor expression in broad populations of
memory CD4 T cells. Several findings were obtained and are
summarized as follows: CXCR3 and CCR6 were highly biased
to type-1 memory CD4 T cells; post-sensitization-induced
chemokine transcripts were distinctly associated with CD44
memory T cells; CCR4 and CCR8 were enhanced following Ag
stimulation and were expressed by type-1 and type-2 CD4 T
memory populations; CCR3 transcripts were associated with
nonmemory CD4 T cell fractions; and CCR4 transcripts
showed the strongest association with IFN-- and IL-4-produc-
ing cells. It should be emphasized that our findings describe
events within reactive lymph nodes, but additional modifica-
tions of chemokine receptors may occur in other compartments
such as blood and inflammatory sites. For example, Kim et al.
[51] demonstrated CCR7 expression by circulating blood mem-
ory Th cells, possibly allowing for lymphoid tissue recircula-
tion. Further understanding of chemokine receptor dynamics
will require more detailed subpopulation and compartment
analyses as well as the use of murine chemokine receptor-
specific Ab as they become available.
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